Target intelligence / Profile preview

FBLIM1 pseudogene 2 (FBLIM1P2)

Target
FBLIM1P2
Molecular classification
Other (pseudogene)
01

Overview

FBLIM1P2 (FBLIM1 pseudogene 2) is a human pseudogene, meaning it is a nonfunctional genomic copy related to the protein-coding FBLIM1 gene[5][7]. Pseudogenes do not code for proteins and typically lack biological function or therapeutic relevance. FBLIM1P2 has no recognized role in cellular processes, disease, or as a drug target. It is not considered a molecular target for therapeutics and does not participate in disease mechanisms or drug interactions.

Other names
FBLIM1P2HGNC:55108NCBI Gene:401679Ensembl:ENSG00000254871

Beyond the preview

Go deeper on FBLIM1 pseudogene 2 (FBLIM1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FBLIM1 pseudogene 2 (FBLIM1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call